Plasmodium yoelii nigeriensis (MDR)—Efficacy of Oral Pyronaridine against Multidrug-Resistant Malaria in Swiss Mice

Bodley, 1998, Effect of camptothecin, a topoisomerase I inhibitor on Plasmodium falciparum, Biochemical Pharmacology, 55, 709, 10.1016/S0006-2952(97)00556-X Bunnag, 1991, Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand: A preliminary report, South East Asian Journal of Tropical Medicine & Public Health, 22, 380 Chavalitschewinkoon, 1993, Structure activity relationships and modes of action of a-anilinoacridines against chloroquine resistant Plasmodium falciparum in vitro, Antimicrobial Agents & Chemotherapy, 37, 403, 10.1128/AAC.37.3.403 Childs, 1988, In vitro activity of pyronaridine against field isolates and reference clones of Plasmodium falciparum, American Journal of Tropical Medicine Hygiene, 38, 24, 10.4269/ajtmh.1988.38.24 Dorn, 1998, An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials, Biochemical Pharmacology, 55, 727, 10.1016/S0006-2952(97)00510-8 Dutta, 1990, Antimalarial efficacy of arteether against multiple drug resistant strain of Plasmodium yoelii nigeriensis, Pharmacological Research, 21, 415, 10.1016/1043-6618(89)90159-X Elueze, 1996, Activity of pyronaridine and mepacrine against twelve strains of Plasmodium falciparum in vitro, Journal of Antimicrobial & Chemotherapy, 37, 511, 10.1093/jac/37.3.511 Fu, 1991, Pyronaridine: A new antimalarial drug, Parasitology Today, 7, 310, 10.1016/0169-4758(91)90267-R Looareesuwan, 1996, Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand, American Journal of Tropical Medicine and Hygiene, 54, 205, 10.4269/ajtmh.1996.54.205 Onori, 1989, Recent acquisitions on chemotherapy and chemoprophylaxis of malaria, Annual Ist Super Sanital, 25, 659 Peters, 1992, The chemotherapy of rodent malaria, XLVII. Studies on pyronaridine and other mannich base antimalarials, Annals of Tropical Medicine & Parasitology, 86, 455, 10.1080/00034983.1992.11812694 Pradines, 1998, In vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents, Journal of Antimicrobial Chemotherapy, 42, 333, 10.1093/jac/42.3.333 Ringwald, 1998, Efficacy of oral pyronaridine for the treatment of acute uncomplicated falciparum malaria in African children, Clinical Infectious Diseases, 26, 946, 10.1086/513942 Ringwald, 1996, Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa, The Lancet, 347, 24, 10.1016/S0140-6736(96)91558-5 Shao, 1990, A review of antimalarial drug pyronaridine, Chinese Medical Journal, 103, 428 Valecha, 1997, Efficacy of α/β arteether in acute uncomplicated P. falciparum malaria, International Journal of Clinical Pharmacology Research, 17, 11 Winstanley, 1996, Pyronaridine: A promising drug for Africa?, Lancet, 347, 2, 10.1016/S0140-6736(96)91548-2 1984, Technical Report Wu, 1988, Morphological effects of pyronaridine on malarial parasites, American Journal of Tropical Medicine and Hygiene, 38, 30, 10.4269/ajtmh.1988.38.30 Yang, 1997, In vitro sensitivity of Plasmodium falciparum to eight antimalarials in China-Myanmar and China-Lao PDR border areas, Southeast Asian Journal of Tropical Medicine and Public Health, 28, 460 Zheng, 1982, Synthesis of a new antimalarial drug pyronaridine, and its analogues, Acta Pharmacological Sinica, 17, 118